Macrolide antibiotic. Specific vacuolar-type H+-ATPase inhibitor. Distinguishes among different types of ATPases. Inhibitor of endosomal, lysosomal and vacuolar acidification. Prevents lysosomal Ca2+ uptake. Inhibitor of autophagic degradation by rising pH and thus inactivating the lysosomal acid hydrolases. Neuroprotective.
More Information Supplier Page
Macrolide antibiotic. Specific vacuolar-type H+-ATPase inhibitor. Distinguishes among different types of ATPases. Inhibitor of endosomal, lysosomal and vacuolar acidification. Prevents lysosomal Ca2+ uptake. Inhibitor of autophagic degradation by rising pH and thus inactivating the lysosomal acid hydrolases. Neuroprotective.
More Information Supplier Page 
Less toxic, more potent synthetic derivative of geldanamycin (Prod. No. BVT-0196). Angiogenesis inhibitor. Heat shock protein 90 (HSP90) inhibitor. Apoptosis inducer. Shows higher antitumor activity than 17-AAG (Prod. No. BVT-0244).
More Information Supplier Page
Antibiotic. Antitumor compound. Weakly active against Gram-positive bacteria and fungi. Mediates a unique cross-linking reaction between DNA and histone H3 by light. Single strand scission and covalent binding to DNA after photoactivation.
More Information Supplier Page
Pyridone metabolite. Nitric oxide synthase (NOS) inhibitor, showing selectivity for eNOS (NOS III) versus nNOS (NOS I). Thaxtomine biosynthesis inhibitor. Mitochondrial electron transport chain inhibitor.
More Information Supplier Page
Antibiotic. Antitumor compound. Shows weak cytotoxicity against different tumor cell lines.
More Information Supplier Page
Antibiotic. Antitumor compound. Shows weak cytotoxicity against different tumor cell lines.
More Information Supplier Page 
Antibiotic. Semisynthetic water-soluble derivative of rebeccamycin (Prod. No. BVT-0139). Antitumor compound. Topoisomerase II (Topo II) inhibitor. DNA intercalating agent.
More Information Supplier Page
